Skip to main content
Guidance

PHE monitoring of the effectiveness of COVID-19 vaccination

Data on the real-world efficacy of the COVID-19 vaccines.

Updates to this page

From:
Public Health England
Published:
22 February 2021
Last updated:
14 September 2021
Show all updates

  1. Added link to 'vaccine effectiveness and duration of protection study'.

  2. Added link to Different dosing schedules and vaccine effectiveness study.

  3. Added link to vaccine effectiveness in clinical risk groups report.

  4. Added 'Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality' report.

  5. Added link to 'Vaccine effectiveness with Delta variant'.

  6. Updated PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England, March 2021 - title of figure 1 corrected.

  7. Added link 'Vaccine effectiveness with B.1.617.2 variant'.

  8. Added link to weekly surveillance report.

  9. Added link to the effectiveness of COVID-19 vaccines on mortality study, effectiveness of COVID-19 vaccines against hospitalisation study and summary of evidence on vaccine effectiveness against different outcomes.

  10. Added link to 'Impact of vaccination on household transmission of SARS-COV-2 in England'.

  11. Added links to the VIVALDI and Avon CAP studies.

  12. Added December 2020 to March 2021 report.

  13. Added link to Early effectiveness of COVID-19 vaccines in older adults.

  14. Added Impact of COVID-19 vaccines on mortality in England: December 2020 to February 2021.

  15. Added latest version of report and link to seroprevalence document.

  16. Added link to the SIREN study.

  17. First published.

Documents

Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality

Ref: PHE publications gateway number: GOV-8775

PDF, 910 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Impact of COVID-19 vaccines on mortality in England: December 2020 to March 2021

Ref: PHE publications gateway number: GOV-7989

PDF, 624 KB, 8 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Impact of COVID-19 vaccines on mortality in England: December 2020 to February 2021

Ref: PHE gateway number GOV-7803

PDF, 576 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England, March 2021

Ref: PHE publications gateway number: GOV-7777

PDF, 625 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England, February 2021

Ref: PHE publications gateway number: GW-1970

PDF, 1.15 MB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

On 8 December 2020, the UK became the first country to roll out a coronavirus (COVID-19) vaccination programme, initially using the Pfizer/BioNTech vaccine.

Since the beginning of the programme, Public Health England (PHE) has been monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy and has now published its first analysis of the impact of the Pfizer/BioNTech vaccine on:

  • symptomatic disease
  • hospitalisation
  • death
  • infection (symptomatic or asymptomatic)

For the latest reports please see the UK Health Security Agency monitoring reports of the effectiveness of COVID-19 vaccination.

Weekly COVID-19 vaccine surveillance reports are available.

Sign up for emails or print this page

Related content